Abstract The invention relates to a certain oral dosage form providing absorption of the drug diclofenac in an ultrafast manner.

The invention relates to pharmaceutical compositions suitable for oral administration in the form of edible films comprising diclofenac.

A combination of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile and an NSAID that is a COX-2 inhibitor. The combination is used for the treatment of chronic pain, rheumatoid arthritis and osteoarthritis. The NSAID can be diclofenac.

Disclosed is a topical opaque emulsion-gel which comprises (a) diclofenac diethylammonium salt, (b) saturated or unsaturated C10-C18 fatty alcohol selected from the group consisting of stearyl alcohol, myristyl alcohol, lauryl alcohol and oleyl alcohol, (c) water, (d) at least one C2-C4 alkanol, (e) at least one glycol solvent selected from the group consisting of 1,2-propanediol and polyethylene glycol, (f) at least one gelling agent selected from the group consisting of carbomers, (g at least ...

Disclosed is the use of a pharmaceutically acceptable diclofenac salt for the manufacture of a soft gelatin capsule for the ultrafast oral treatment of pain, wherein said pharmaceutically acceptable diclofenac salt (preferably diclofenac potassium) is present in said soft gelatin capsule in solution

FIELD medicine pharmaceutics. ^ SUBSTANCE invention relates to pharmaceutical composition for peroral introduction in form of food film where food film includes diclofenac in form of free acid or diclofenac resinate in amount from 10 to 50 wt % and film-forming polymer in amount from 10 to 80 wt % per dry weight of obtained food film. Composition contains from 10 to 50 mg of diclofenac in dissolved or evenly dispersed state food film being 20-250 mcm thick. ^ EFFECT invention ensures fast decomp...

The invention relates to coated tablets comprising the pharmaceutically active substance diclofenac. Said tablets further comprise a single film coating.

Disclosed is a pharmaceutical composition for oral administration in the form of an edible film, which edible film comprises free acid or a diclofenac resinate, at least one film forming polymer (A) and at least one plasticizer (B), and which edible film completely disintegrates in the mouth of a patient in less than 60 seconds. Suitable film forming polymers (A) are hydroxypropylmethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, cellulose phthalate and mixtures thereof. Suitable...